Elcys

Active Ingredient(s): Cysteine Hydrochloride
FDA Approved: * April 16, 2019
Pharm Company: * EXELA PHARMA SCS LLC
Category: Neonatal (Infant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Elcys Overview

Cysteine (symbol Cys or C;[3] /sstiin/)[4] is a semiessential[5] proteinogenic amino acid with the formula HO2CCH(NH2)CH2SH. The thiol side chain in cysteine often participates in enzymatic reactions, as a nucleophile. The thiol is susceptible to oxidation to give the disulfide derivative cystine, which serves an important structural role in many proteins. When used as a food additive, it has the E number E920. It is encoded by the codons UGU ...

Read more Elcys Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cysteine

Recent Elcys Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cysteine Hydrochloride
  • Injection: 50mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cysteine Hydrochloride or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 May 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA